BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11575390)

  • 1. Use of cisatracurium during fast-track cardiac surgery.
    Ouattara A; Richard L; Charrière JM; Lanquetot H; Corbi P; Debaene B
    Br J Anaesth; 2001 Jan; 86(1):130-2. PubMed ID: 11575390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion.
    Mellinghoff H; Radbruch L; Diefenbach C; Buzello W
    Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cisatracurium-induced neuromuscular block at the masseter and adductor pollicis muscle.
    de Rossi L; Fritz H; Klein U
    Eur J Anaesthesiol; 2000 Sep; 17(9):583-6. PubMed ID: 11029126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
    Prielipp RC; Coursin DB; Scuderi PE; Bowton DL; Ford SR; Cardenas VJ; Vender J; Howard D; Casale EJ; Murray MJ
    Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium.
    Carroll MT; Mirakhur RK; Lowry D; Glover P; Kerr CJ
    Anaesthesia; 1998 Aug; 53(8):744-8. PubMed ID: 9797517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisatracurium in cardiac surgery--continuous infusion vs. bolus administration.
    Mirinejad M; Azarfarin R; Asl AA
    Middle East J Anaesthesiol; 2007 Oct; 19(3):563-72. PubMed ID: 18044284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The infusion requirements and recovery characteristics of cisatracurium or atracurium in intensive care patients.
    Pearson AJ; Harper NJ; Pollard BJ
    Intensive Care Med; 1996 Jul; 22(7):694-8. PubMed ID: 8844237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block.
    Kirkegaard H; Heier T; Caldwell JE
    Anesthesiology; 2002 Jan; 96(1):45-50. PubMed ID: 11753000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of sevoflurane versus propofol-remifentanil anesthesia on neuromuscular blockade by continuous cisatracurium infusion].
    Wen LL; Lin WQ; Zhao WX; Li GC; Bai XH; Xiao JB
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):163-5. PubMed ID: 20118012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cisatracurium in children during halothane-nitrous oxide anesthesia.
    Brandom BW; Woelfel SK; Ference A; Dayal B; Cook DR; Kerls S
    J Clin Anesth; 1998 May; 10(3):195-9. PubMed ID: 9603588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative residual curarization with cisatracurium and rocuronium infusions.
    Cammu G; de Baerdemaeker L; den Blauwen N; de Mey JC; Struys M; Mortier E
    Eur J Anaesthesiol; 2002 Feb; 19(2):129-34. PubMed ID: 11999596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recovery of neuromuscular block after continuous infusion of cisatracurium in patients with renal dysfunction].
    Sztark F; Cantini O; Bourdallé-Badie C; Gardien PL; Erny P
    Ann Fr Anesth Reanim; 2001 May; 20(5):446-51. PubMed ID: 11419239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular blocking effects of cisatracurium and its antagonism with neostigmine in a canine model of autosomal-recessive centronuclear myopathy.
    Martin-Flores M; Paré MD; Campoy L; Gleed RD
    Br J Anaesth; 2015 Dec; 115(6):927-31. PubMed ID: 26582854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular interaction of sevoflurane--cisatracurium in a myasthenic patient.
    Baraka AS; Taha SK; Kawkabani NI
    Can J Anaesth; 2000 Jun; 47(6):562-5. PubMed ID: 10875720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the neuromuscular blocking effect of cisatracurium and atracurium on the larynx and the adductor pollicis.
    Kirov K; Motamed C; Decailliot F; Behforouz N; Duvaldestin P
    Acta Anaesthesiol Scand; 2004 May; 48(5):577-81. PubMed ID: 15101851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of neuromuscular blocking and hemodynamic effects of rocuronium and cisatracurium under sevoflurane or total intravenous anesthesia.
    Amin AM; Mohammad MY; Ibrahim MF
    Middle East J Anaesthesiol; 2009 Feb; 20(1):39-51. PubMed ID: 19266825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized comparison of train-of-four monitoring and clinical assessment during continuous ICU cisatracurium paralysis.
    Baumann MH; McAlpin BW; Brown K; Patel P; Ahmad I; Stewart R; Petrini M
    Chest; 2004 Oct; 126(4):1267-73. PubMed ID: 15486392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on the pharmacodynamics of cisatracurium: continuous infusion or intermittent bolus injection.
    Dong YJ; Li X
    Contemp Clin Trials; 2012 May; 33(3):482-5. PubMed ID: 22269820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.